AlphanoxLtd Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 4/6
AlphanoxLtd has a total shareholder equity of ₩23.6B and total debt of ₩25.8B, which brings its debt-to-equity ratio to 109.3%. Its total assets and total liabilities are ₩58.6B and ₩35.0B respectively.
Wichtige Informationen
109.3%
Verhältnis von Schulden zu Eigenkapital
₩25.78b
Verschuldung
| Zinsdeckungsgrad | n/a |
| Bargeld | ₩11.68b |
| Eigenkapital | ₩23.60b |
| Gesamtverbindlichkeiten | ₩35.04b |
| Gesamtvermögen | ₩58.63b |
Jüngste Berichte zur Finanzlage
Recent updates
Investors Don't See Light At End Of Alphanox Co.,Ltd.'s (KOSDAQ:043100) Tunnel And Push Stock Down 27%
Sep 30
Is Solco Biomedical (KOSDAQ:043100) Using Debt In A Risky Way?
Jun 27Solco Biomedical Co., Ltd.'s (KOSDAQ:043100) 27% Dip In Price Shows Sentiment Is Matching Revenues
Jun 27Solco Biomedical Co., Ltd.'s (KOSDAQ:043100) Share Price Boosted 40% But Its Business Prospects Need A Lift Too
Feb 27Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: A043100's short term assets (₩33.5B) exceed its short term liabilities (₩33.0B).
Langfristige Verbindlichkeiten: A043100's short term assets (₩33.5B) exceed its long term liabilities (₩2.1B).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: A043100's net debt to equity ratio (59.8%) is considered high.
Schulden abbauen: A043100's debt to equity ratio has increased from 35.2% to 109.3% over the past 5 years.
Bilanz
Liquiditätsreserve-Analyse
Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.
Stabile Start- und Landebahn für Bargeld: A043100 has sufficient cash runway for more than a year based on its current free cash flow.
Vorhersage Cash Runway: A043100 has sufficient cash runway for 1.2 years if free cash flow continues to grow at historical rates of 7.4% each year.